業績

2017年

  1. Nitta K, Yajima A, Tsuchiya K. Management of Osteoporosis in Chronic Kidney Disease. Intern Med. 2017 Dec 15;56(24):3271-3276.
  2. Ishizaki J, Takemori A, Suemori K, Matsumoto T, Akita Y, Sada KE, Yuzawa Y, Amano K, Takasaki Y, Harigai M, Arimura Y, Makino H, Yasukawa M, Takemori N, Hasegawa H; Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan. Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Re s Ther. 2017 Sep 29;19(1):218
  3. Inoue D, Usui R, Nitta K, Koike M. A case of acetaminophen-induced acute tubulointerstitial nephritis in adult. CEN Case Rep. 2017 Nov;6(2):185-188.
  4. Hanafusa N, Yamamoto H, Tamachi M, Torato T, Sakurai S, Tsuchiya K, Nitta K, Nangaku M. Efficacy of Substance Removal by Immunoadsorption With a Selective Plasma Separator. Ther Apher Dial. 2017 Jun;21(3):218-225.
  5. Kamei D, Tsuchiya K, Nitta K, Mineshima M, Akiba T. Association between resistance to erythropoiesis-stimulating agents and carnitine profile in patients on maintenance hemodialysis. Nephrology (Carlton). 2017 Jun 13. doi: 10.1111/nep.13079. [Epu b ahead of print]
  6. Manabe S, Hatano M, Nakano M, Fujii T, Nitta K, Nagata M. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report. Pathol Int. 2017 Aug;67(8):419-42 4.
  7. Manabe S, Banno M, Nakano M, Fujii T, Kakuta Y, Nitta K, Hatano M. A case of PR3-ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy. CEN Case Rep. 2017 May;6(1):39-45.
  8. Omae K, Yoshikawa M, Sakura H, Nitta K, Ogawa T.Efficacy of antihistamines on mortality in patients receiving maintenance hemodialysis: an observational study using propensity score matching. Heart Vessels. 2017 Oct;32(10):1195-1201.
  9. Usui R, Takahashi M, Nitta K, Koike M. Five-year follow-up of a case of lipoprotein glomerulopathy with APOE Kyoto mutation. CEN Case Rep. 2016 Nov;5(2):148-153.
  10. Takura T, Takei T, Nitta K. Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan.Sci Rep. 2017 Apr 7;7:46036.
  11. Kumon S, Usui R, Kuzuhara S, Nitta K, Koike M. The Improvement of the Outcome of Osmotic Demyelination Syndrome by Plasma Exchange. Intern Med. 2017;56(6):733-736.
  12. Moriyama T, Sasaki K, Karasawa K, Uchida K, Nitta K. Intracellular transcytosis of albumin in glomerular endothelial cells after endocytosis through caveolae. J Cell Physiol. 2017 Dec;232(12):3565-3573.
  13. Masakane I, Hasegawa T, Ogata S, Kimata N, Nakai S, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. Peritoneal Dialysis Registry With 2013 Survey Report. Ther Apher Dial. 2016 Dec;20(6):557-568.
  14. Sato M, Takei T, Moriyama T, Itabashi M, Nitta K. Long-term outcomes of initial therapy for idiopathic membranous nephropathy. Clin Exp Nephrol. 2017 Oct;21(5):842-851.
  15. Kamei D, Tsuchiya K, Miura H, Nitta K, Akiba T. Inter-Method Variability of Ferritin and Transferrin Saturation Measurement Methods in Patients on Hemodialysis. Ther Apher Dial. 2017 Feb;21(1):43-51.
  16. Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A; CKD-JAC Investigators. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017 Jan;91(1):227-234.
  17. Hirose O, Itabashi M, Takei T, Honda K, Nitta K. Antineutrophil cytoplasmic antibody-associated glomerulonephritis with immunoglobulin deposition. Clin Exp Nephrol. 2017 Aug;21(4):643-650.
  18. Unagami K, Ishida H, Okumi M, Hirai T, Toki D, Omoto K, Shimizu T, Inui M, Nitta K, Tanabe K. Assessment of 4 Cases of Kidney Transplantation from Hepatitis C Virus Antibody-Positive and RNA-Negative Donors to Antibody-Negative Recipients. Transp lant Direct. 2016 Aug 26;2(9):e102.
  19. Momoki K, Kataoka H, Moriyama T, Mochizuki T, Nitta K. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. J Atheroscler Thromb. 2017 Jun 1;24(6):630-642.
  20. Nishida M, Ando M, Iwamoto Y, Tsuchiya K, Nitta K. New Insight into Atherosclerosis in Hemodialysis Patients: Overexpression of Scavenger Receptor and Macrophage Colony-Stimulating Factor Genes. Nephron Extra. 2016 Aug 27;6(2):22-30.
  21. Momoki K, Yamaguchi T, Ohashi K, Ando M, Nitta K. Emergence of Dipstick Proteinuria Predicts Overt Nephropathy in Patients Following Stem Cell Transplantation. Nephron. 2017;135(1):31-38.
  22. Naito T, Sanaka T, Mikami H, Soga A, Yamatani K, Segawa K, Kawashima M, Yoshikura T, Niwayama J, Nishimura H, Ogawa T, Ando A, Teramoto A, Nitta K. Modulation of circulating endothelial progenitor cells by erythropoiesis-stimulating agents in pat ients with chronic kidney disease stage G5 and 5D?. Clin Nephrol. 2016 Nov;86 (2016)(11):242-252.
  23. Tokoroyama T, Ando M, Setoguchi K, Tsuchiya K, Nitta K. Prevalence, incidence and prognosis of chronic kidney disease classified according to current guidelines: a large retrospective cohort study of rheumatoid arthritis patients. Nephrol Dial Transplant. 2017 Dec 1;32(12):2035-2042.
  24. Hoshino Y, Moriyama T, Uchida K, Tsuchiya K, Nitta K. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy. Clin Exp Nephrol. 2017 Aug;21(4):617-623.
  25. Akiyama K, Mochizuki T, Kataoka H, Tsuchiya K, Nitta K. Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease. Nephrology (Carlton). 2017 Nov;22(11):848-853.
  26. Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Hishida A; Chronic Kidney Disease Japan Cohort Study Group. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disea se Japan Cohort (CKD-JAC) study. Clin Exp Nephrol. 2017 Jun;21(3):446-456.
  27. Hara M, Yanagisawa N, Ohta A, Momoki K, Tsuchiya K, Nitta K, Ando M. Increased non-HDL-C level linked with a rapid rate of renal function decline in HIV-infected patients. Clin Exp Nephrol. 2017 Apr;21(2):275-282.